+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 12Years +
All Genders
ID07765888

Evaluating Tilrekimig With Medicated Creams in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

Led by Pfizer · Updated on 2026-10-15

375

Participants Needed

21

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how well tilrekimig works and how safe it is when combined with medicated creams or ointments in adults and adolescents aged 12 years or older who have moderate to severe atopic dermatitis, also known as eczema. This common skin condition causes dry, itchy, red, and irritated skin. The study focuses on participants who have had atopic dermatitis for at least 12 months and have not responded well to standard topical treatments. Participants will be randomly assigned in a 21 ratio to receive either tilrekimig or a placebo through subcutaneous injections over a 20-week period. The study treatment period lasts 24 weeks, with the last dose given at week 20. After completing this phase, some participants may join a long-term extension study to continue monitoring the effects and safety of tilrekimig, while others will enter a 12-week safety follow-up ending 16 weeks after their last dose. During the study, participants will be monitored closely with evaluations including eczema severity assessments, quality of life questionnaires, and safety checks such as vital signs and laboratory tests. Researchers will measure outcomes like the proportion of participants showing improvement in eczema severity at week 16. The total participation time includes the treatment period and follow-up, lasting several months to assess both short-term and longer-term effects of the study medicine.

CONDITIONS

Brief Title

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Research Team

P

Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here